Inactive Instrument

Oscar Investments Limited

501179

INE221D01018

Investment Management & Fund Operators

Oscar Investments Limited Announces the Resignation of Varun Sood as Director

February 21, 2018 at 04:46 am EST

Oscar Investments Limited announced that Mr. Varun Sood, Managing Director of the Company has also resigned as Director of the company with effect from February 20, 2018 due to pre occupation.

Latest news about Oscar Investments Limited

Yes Bank Announces to Sell Properties of Avantha Holdings and Oscar Investment	20-07-05	CI
Oscar Investments Limited Announces Change in Registered Office Address	18-10-22	CI
Oscar Investments Limited Proposes Board Appointments	18-08-14	CI
Oscar Investments Limited Announces Resignation of Aditi Shivinder Singh as its Non- Executive Director	18-06-08	CI
Oscar Investments Limited Announces Standalone Earnings Results for the Fourth Quarter and Full Year and Consolidated Earnings Results for the Full Year Ended March 31, 2018	18-06-06	CI
Oscar Investments Ltd. cancelled the acquisition of the remaining 93.9% stake in HealthFore Technologies Limited from RHC Holding Private Limited and others.	18-05-02	CI
Oscar Investments Limited Announces Resignation of Preetinder Singh Joshi, Director	18-04-12	CI
Oscar Investments Limited Announces Resignation of Ravi Sikka, Independent Non- Executive Director	18-03-02	CI
Oscar Investments Limited Announces the Resignation of Varun Sood as Director	18-02-21	CI
Oscar Investments Limited Announces Unaudited Standalone Earnings Results for Third Quarter and Nine Months Ended December 31, 2017	18-02-14	CI
Oscar Investments Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2017	17-11-13	CI
Oscar Investments Limited Oscar Investments Limited Announces Resignation of Vivek Kumar Singh as Company Secretary and Compliance Officer	17-09-14	CI
Oscar Investments Limited Announces Resignation of Ravi Sikka as Independent Non-Executive Director	17-08-18	CI
Oscar Investments Limited Appoints Varun Sood as Managing Director	17-08-16	CI
Oscar Investments Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2017	17-08-11	CI
Oscar Investments Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2017 and Consolidated Earnings Results for the Year Ended March 31, 2017; Approves Shifting of Registered Office from 54 Janpath, New Delhi 110001 to 1, Rajesh Pilot Lane, New Delhi - 110011	17-05-29	CI
Oscar Investments Limited' Board Appoints Mr. Vivek Kumar Singh as the Company Secretary, Compliance Officer and Key Managerial Person	17-05-29	CI
Oscar Investments Limited Announces Unaudited Standalone and Consolidated Earnings Results for Third Quarter and Nine Months Ended December 31, 2016	17-02-14	CI
Oscar Investments Limited Announces Resignation of Karishma Jain as Company Secretary & Compliance Officer	17-01-16	CI
Oscar Investments Ltd. Reports Audited Standalone and Consolidated Cash Flow Results for the Year Ended March 31, 2016	16-11-24	CI
Oscar Investments Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2016	16-11-11	CI
Oscar Investments Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2016	16-08-12	CI
Oscar Investments Ltd. Reports Audited Standalone Earnings Results for the Fourth Quarter and Standalone and Consolidated Earnings Results for the Full Year Ended March 31, 2016	16-05-26	CI
Oscar Investments Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015	16-02-05	CI
Oscar Investments Ltd. agreed to acquire the remaining 93.9% stake in HealthFore Technologies Limited from RHC Holding Private Limited and others for approximately INR 280 million, in a scheme of amalgamation.	15-12-13	CI

Chart Oscar Investments Limited

Duration

Period

More charts

Oscar Investments Limited is an India-based non-banking finance company. The Company is primarily engaged in the business of income from financial activity. The Company focuses on the business of an investment company, finances industrial enterprise, and promotes companies engaged in industrial and trading business. The Company is involved in the other financial service activities, except insurance and pension funding activities. The Company has a subsidiary Shimal Research Laboratories Limited and a sub-subsidiary, Fortis Clinical Research Limited.

Sector

Investment Management & Fund Operators

More about the company

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
BLACKROCK, INC.	-5.49%	116B
UBS GROUP AG	+8.47%	99.76B
BROOKFIELD CORPORATION	+12.10%	68.91B
APOLLO GLOBAL MANAGEMENT, INC.	+23.96%	65.73B
BANK OF NEW YORK MELLON CORPORATION (THE)	+12.05%	44.19B
AMERIPRISE FINANCIAL, INC.	+14.63%	43.8B
3I GROUP PLC	+20.69%	36.34B
T. ROWE PRICE GROUP INC.	+7.93%	26.39B
STATE STREET CORPORATION	-4.72%	22.71B

Other Investment Management & Fund Operators